Order For Research Use
Explore our BPC-157 and TB-500 formats and review COAs before ordering.
BPC-157 & TB-500: Investigated Peptides in Preclinical Research
Research Peptides
BPC-157 & TB-500: Research Overview
Peptide-based compounds like BPC-157 and TB-500 have gained significant attention in scientific and preclinical research settings. Both are synthetic sequences modeled after naturally occurring peptides, studied for their potential roles in cellular processes such as angiogenesis, tissue modulation, and cellular migration.
Compliance note: All compounds are for laboratory research use only. They are not approved for human or veterinary use. No medical or usage claims are made.
Overview of BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic peptide sequence derived from a partial fragment of a gastric protein known as Body Protection Compound (BPC).
In preclinical models, researchers have examined its role in:
- Cytoprotection – observation of cellular response to oxidative or chemical stress
- Angiogenesis – influence on growth factors and endothelial signaling
- Fibroblast activity – modulation of cellular migration in wound models
Research remains strictly non-clinical, focused on understanding biochemical interactions rather than therapeutic outcomes. Studies often utilize in-vitro assays and controlled animal experiments to analyze receptor pathways and molecular binding activity.
Overview of TB-500
TB-500, a synthetic fragment of Thymosin Beta-4, represents a sequence that has been studied for its regulatory influence in cellular actin binding.
In laboratory environments, TB-500 has been explored for:
- Actin-binding modulation – effect on cell structure and movement
- Angiogenic signaling – influence on blood vessel formation in tissue models
- Cytoskeletal organization – cell motility and tissue modeling research
These investigations aim to map signal pathways and protein-protein interactions that could inform future molecular or cellular research, not for human or clinical use.
Comparative Discussion
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Synthetic derivative of gastric BPC protein | Synthetic sequence of Thymosin Beta-4 |
| Molecular focus | Cytoprotection, angiogenesis, fibroblast migration | Actin modulation, angiogenesis, cytoskeletal organization |
| Research use | Cellular assays, biochemical modeling | Molecular signaling, protein interaction studies |
| Stability factors | pH and temperature-dependent | Lyophilized format enhances stability |
While both peptides are often examined in similar preclinical contexts, their molecular pathways differ significantly. Using verified high-purity compounds is essential to ensure data accuracy during comparative or co-administration testing in lab environments.
Analytical Verification
At Pure Bio Labs, all BPC-157 and TB-500 research peptides are:
- Verified by High-Performance Liquid Chromatography (HPLC)
- Cross-checked with Mass Spectrometry (MS) for molecular weight accuracy
- Supplied with batch-specific Certificates of Analysis (COA)
These procedures confirm molecular identity and purity, ensuring reliability for in-vitro and ex-vivo experimental applications.
Storage & Handling Recommendations
- Store in lyophilized form at -20°C or below
- Avoid repeated freeze-thaw cycles
- Reconstitute only with sterile, research-grade solvent immediately before use
- Document batch numbers and testing logs for traceability
FAQ
- What is BPC-157 used for in research?
- BPC-157 is studied in laboratory environments for cellular processes such as angiogenesis, oxidative response, and fibroblast migration. All studies are preclinical.
- What is TB-500 used for in research?
- TB-500 is examined for interaction with actin and roles in cellular motility, angiogenesis, and cytoskeletal dynamics in preclinical settings.
- Are these compounds for human use?
- No. Both are intended strictly for laboratory research. They are not approved for human or veterinary applications.